CVS — CVS Health Corporation
In 2026 Q2, 11 of the 140 tracked hedge funds reported a position in CVS Health Corporation (CVS), worth $149.59M combined. Over the quarter 5 opened or added, 6 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $45.62M | 0.06% | +67.6% |
| Polar Capital | $43.64M | 0.12% | -13.5% |
| VanEck | $23.40M | 0.01% | -85.5% |
| Colrain | $15.41M | 5.20% | +0% |
| IMC | $10.60M | 0.10% | +18.2% |
| Ardsley | $4.14M | 0.45% | -52.9% |
| BOCHK | $3.29M | 0.52% | NEW |
| Barnes Dennig | $1.99M | 1.60% | -2.9% |
| Steadtrust | $949.15K | 0.48% | NO CHANGE |
| Cypress Point | $274.04K | 0.06% | NEW |
| Chapin Davis | $273.32K | 0.05% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.